Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rang in Aktien #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Aktienkurs
$1.49
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$10.94M
Veränderung (1 Tag)
4.58%
Veränderung (1 Jahr)
-55.67%
Land
US
Handel Ainos, Inc. (AIMD)

Kategorie

Kursverlauf für Ainos, Inc. (AIMD)
Höchster Schlusskurs: $1.47 am 2026-08-01

Niedrigster Schlusskurs: $69.83 am 2021-01-01
Kursverlauf der Aktie von Ainos, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 6.80%
2025 -6.53%
2024 -82.92%
2023 -21.75%
2022 -92.69%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$110.85 -37.09%
AU
$736.64 6.99%
CH
$1.05K -7.52%
KR